1cfj › Citations

Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level.

Millard CB, Kryger G, Ordentlich A, Greenblatt HM, Harel M, Raves ML, Segall Y, Barak D, Shafferman A, Silman I, Sussman JL
Biochemistry 38 7032-9 (1999)
Related entries: 1som, 2dfp

Cited: 125 times
EuropePMC logo PMID: 10353814

Abstract

Organophosphorus acid anhydride (OP) nerve agents are potent inhibitors which rapidly phosphonylate acetylcholinesterase (AChE) and then may undergo an internal dealkylation reaction (called "aging") to produce an OP-enzyme conjugate that cannot be reactivated. To understand the basis for irreversible inhibition, we solved the structures of aged conjugates obtained by reaction of Torpedo californica AChE (TcAChE) with diisopropylphosphorofluoridate (DFP), O-isopropylmethylphosponofluoridate (sarin), or O-pinacolylmethylphosphonofluoridate (soman) by X-ray crystallography to 2.3, 2.6, or 2.2 A resolution, respectively. The highest positive difference density peak corresponded to the OP phosphorus and was located within covalent bonding distance of the active-site serine (S200) in each structure. The OP-oxygen atoms were within hydrogen-bonding distance of four potential donors from catalytic subsites of the enzyme, suggesting that electrostatic forces significantly stabilize the aged enzyme. The active sites of aged sarin- and soman-TcAChE were essentially identical and provided structural models for the negatively charged, tetrahedral intermediate that occurs during deacylation with the natural substrate, acetylcholine. Phosphorylation with DFP caused an unexpected movement in the main chain of a loop that includes residues F288 and F290 of the TcAChE acyl pocket. This is the first major conformational change reported in the active site of any AChE-ligand complex, and it offers a structural explanation for the substrate selectivity of AChE.

Articles - 1cfj mentioned but not cited (5)

  1. Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics. Xu Y, Colletier JP, Weik M, Jiang H, Moult J, Silman I, Sussman JL. Biophys J 95 2500-2511 (2008)
  2. In vitro neuroprotective activities of compounds from Angelica shikokiana Makino. Mira A, Yamashita S, Katakura Y, Shimizu K. Molecules 20 4813-4832 (2015)
  3. Crystal structures of brain group-VIII phospholipase A2 in nonaged complexes with the organophosphorus nerve agents soman and sarin. Epstein TM, Samanta U, Kirby SD, Cerasoli DM, Bahnson BJ. Biochemistry 48 3425-3435 (2009)
  4. Modelling substrate specificity and enantioselectivity for lipases and esterases by substrate-imprinted docking. Juhl PB, Trodler P, Tyagi S, Pleiss J. BMC Struct Biol 9 39 (2009)
  5. Acetylcholine esterase inhibitory activity of green synthesized nanosilver by naphthopyrones isolated from marine-derived Aspergillus niger. Abdelwahab GM, Mira A, Cheng YB, Abdelaziz TA, Lahloub MFI, Khalil AT. PLoS One 16 e0257071 (2021)


Reviews citing this publication (24)

  1. Destruction and detection of chemical warfare agents. Kim K, Tsay OG, Atwood DA, Churchill DG. Chem Rev 111 5345-5403 (2011)
  2. Cholinesterases, a target of pharmacology and toxicology. Pohanka M. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155 219-229 (2011)
  3. Acetylcholinesterase: how is structure related to function? Silman I, Sussman JL. Chem Biol Interact 175 3-10 (2008)
  4. Bacterial detoxification of organophosphate nerve agents. Raushel FM. Curr Opin Microbiol 5 288-295 (2002)
  5. Chemical Aspects of Human and Environmental Overload with Fluorine. Han J, Kiss L, Mei H, Remete AM, Ponikvar-Svet M, Sedgwick DM, Roman R, Fustero S, Moriwaki H, Soloshonok VA. Chem Rev 121 4678-4742 (2021)
  6. Acute and long-term consequences of exposure to organophosphate nerve agents in humans. Figueiredo TH, Apland JP, Braga MFM, Marini AM. Epilepsia 59 Suppl 2 92-99 (2018)
  7. New insights on molecular interactions of organophosphorus pesticides with esterases. Mangas I, Estevez J, Vilanova E, França TC. Toxicology 376 30-43 (2017)
  8. Molecular interactions of cholinesterases inhibitors using in silico methods: current status and future prospects. Khan MT. N Biotechnol 25 331-346 (2009)
  9. Progression of intervention-focused research for Gulf War illness. Chester JE, Rowneki M, Van Doren W, Helmer DA. Mil Med Res 6 31 (2019)
  10. The intriguing biology and chemistry of fosfomycin: the only marketed phosphonate antibiotic. Cao Y, Peng Q, Li S, Deng Z, Gao J. RSC Adv 9 42204-42218 (2019)
  11. Acetylcholinesterase of Schistosoma mansoni--functional correlates. Contributed in honor of Professor Hans Neurath's 90th birthday. Arnon R, Silman I, Tarrab-Hazdai R. Protein Sci 8 2553-2561 (1999)
  12. α-Linolenic Acid, A Nutraceutical with Pleiotropic Properties That Targets Endogenous Neuroprotective Pathways to Protect against Organophosphate Nerve Agent-Induced Neuropathology. Piermartiri T, Pan H, Figueiredo TH, Marini AM. Molecules 20 20355-20380 (2015)
  13. Computational Studies on Acetylcholinesterases. Xu Y, Cheng S, Sussman JL, Silman I, Jiang H. Molecules 22 E1324 (2017)
  14. Microcantilever biosensors based on conformational change of proteins. Ji HF, Gao H, Buchapudi KR, Yang X, Xu X, Schulte MK. Analyst 133 434-443 (2008)
  15. Recent developments in structural studies on acetylcholinesterase. Silman I, Sussman JL. J Neurochem 142 Suppl 2 19-25 (2017)
  16. Why is Aged Acetylcholinesterase So Difficult to Reactivate? Quinn DM, Topczewski J, Yasapala N, Lodge A. Molecules 22 E1464 (2017)
  17. Creation of a protective pulmonary bioshield against inhaled organophosphates using an aerosolized bioscavenger. Rosenberg YJ, Fink JB. Ann N Y Acad Sci 1374 151-158 (2016)
  18. Molecular Recognition of Nerve Agents and Their Organophosphorus Surrogates: Toward Supramolecular Scavengers and Catalysts. Finnegan TJ, Gunawardana VWL, Badjić JD. Chemistry 27 13280-13305 (2021)
  19. Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures. Thompson CM, Gerdes JM, VanBrocklin HF. Neurobiol Dis 133 104455 (2020)
  20. Relationships of human α/β hydrolase fold proteins and other organophosphate-interacting proteins. Lenfant N, Bourne Y, Marchot P, Chatonnet A. Chem Biol Interact 259 343-351 (2016)
  21. Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs. Rosenberg Y, Saxena A. Neuropharmacology 174 108150 (2020)
  22. Connectivity between surface and interior in catalytic subunits of acetylcholinesterases inferred from their X-ray structures. Radić Z. J Neurochem 168 386-396 (2024)
  23. [Neurotoxins with anticholinesterase activity and their possible use as warfare agents]. Pita R, Anadón A, Anadón A, Martínez-Larrañaga MR. Med Clin (Barc) 121 511-517 (2003)
  24. Rate-limiting step in the decarbamoylation of acetylcholinesterases with large carbamoyl groups. Rosenberry TL, Cheung J. Chem Biol Interact 308 392-395 (2019)

Articles citing this publication (96)



Related citations provided by authors (1)

Quick links